KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc.

生物技术研究

Cambridge,Massachusetts 7,877 位关注者

Creating a new generation of small molecule protease inhibitors for HAE and DME.

关于我们

KalVista Pharmaceuticals is a biopharmaceutical company developing oral medicines designed to empower people to enjoy everyday life beyond the challenge of their disease. We apply our expertise to discover, develop and commercialize oral protease inhibitor drugs based on deep expertise in the kallikrein-kinin system. Our commitment to rigorous science is driven by our determination to better address treatment needs for patients, beginning with sebetralstat, our first investigational product for hereditary angioedema (HAE), a rare genetic disease with debilitating attacks of tissue swelling that can be life threatening.

网站
https://kalvista.com
所属行业
生物技术研究
规模
51-200 人
总部
Cambridge,Massachusetts
类型
上市公司

地点

  • 主要

    55 Cambridge Pkwy

    US,Massachusetts,Cambridge,02142

    获取路线

KalVista Pharmaceuticals, Inc.员工

动态

相似主页

查看职位

融资